GPX4 is the ferroptosis core gene, and one recent study speculated that Targeting Wnt/β-catenin signaling by using inhibitors or knocking down TCF4 inhibited the expression of GPX4 and promoted the sensitivity of cancer cells to chemotherapy-induced ferroptosis45. The gene discussed is GPX4; the disease is cancer.